Table 3 The treatment-related any-grade adverse events and grade 3/4 adverse events
Adverse Events, (n) | All Grade | Grade 3/4 |
|---|---|---|
Leukopenia | 7 (19.4%) | 5 (13.9%) |
Anemia | 1 (2.8%) | 1 (2.8%) |
Thrombocytopenia | 3 (8.3%) | 1 (2.8%) |
Fatigue | 3 (8.3%) | 0 |
Nasolacrimal duct obstruction | 1 (2.8%) | 0 |
Sepsis | 1 (2.8%) | 1 (2.8%) |